Epidemiology and Healthcare Resource Utilization of Rett Syndrome in Canada: The Ontario Experience
This study provides population-based estimates of RTT in Ontario. Findings highlight the high burden of illness in RTT in terms of comorbidity prevalence and HCRU. Further research may identify opportunities to improve healthcare outcomes in this population.
Authors
- Laura C. McAdam (ORCID: https://orcid.org/0000-0002-4650-7232)
- Sue Bond (ORCID: https://orcid.org/0000-0001-7440-9720)
- Jillian Murray
- Mubeen F. Rafay (ORCID: https://orcid.org/0000-0003-3922-1225)
- Elsa Rossignol (ORCID: https://orcid.org/0000-0002-9304-9385)
- Calum S. Neish (ORCID: https://orcid.org/0009-0001-0250-1541)
- Anita Datta (ORCID: https://orcid.org/0000-0001-7620-4868)
Institutions
- Acadia Pharmaceuticals (United States) (US)
- University of British Columbia (CA)
- University of Toronto (CA)
- University of Manitoba (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1017/cjn.2025.10475
- Primary Topic
- Genetics and Neurodevelopmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00